Clinical trial
Incidence, Outcome and Prevention of Congenital Human Cytomegalovirus (HCMV) Infection in HCMV-seropositive Pregnant Women
NCT03973359 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence, Outcome and Prevention of Congenital Human Cytomegalovirus (HCMV) Infection in HCMV-seropositive Pregnant Women
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 4, 2017
- Completion date
- December 31, 2020
- Enrollment
- 23,500 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
congenital cytomegalovirus infection, maternal cytomegalovirus infection